Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes

about

Epigenetic Strategies to Boost Cancer Immunotherapies.Decitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2/3 Expression.

P2860

Q33838340-D1F03487-0C9C-4434-B180-706C527E02D9 Q52597632-ECDD909F-BD2E-48B7-BFA7-381CD70E595C

P2860

Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes

Item

http://www.wikidata.org/entity/Q37685237

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Decitabine treatment sensitize ...... with myelodysplastic syndromes

@en

Decitabine treatment sensitize ...... ith myelodysplastic syndromes.

@nl

type

Item

label

Decitabine treatment sensitize ...... with myelodysplastic syndromes

@en

Decitabine treatment sensitize ...... ith myelodysplastic syndromes.

@nl

prefLabel

Decitabine treatment sensitize ...... with myelodysplastic syndromes

@en

Decitabine treatment sensitize ...... ith myelodysplastic syndromes.

@nl

P1476

Decitabine treatment sensitize ...... with myelodysplastic syndromes

@en

P2093

Chao Xiao

http://www.w3.org/2001/XMLSchema#string

Chun-Kang Chang

http://www.w3.org/2001/XMLSchema#string

Dong Wu

http://www.w3.org/2001/XMLSchema#string

Feng Xu

http://www.w3.org/2001/XMLSchema#string

Ji-Ying Su

http://www.w3.org/2001/XMLSchema#string

Juan Guo

http://www.w3.org/2001/XMLSchema#string

Li-Yu Zhou

http://www.w3.org/2001/XMLSchema#string

Ling-Yun Wu

http://www.w3.org/2001/XMLSchema#string

Lu-Xi Song

http://www.w3.org/2001/XMLSchema#string

Qi He

http://www.w3.org/2001/XMLSchema#string

P2860

The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura.

Myelodysplastic syndromes: Contemporary review and how we treat.

Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B.

Distinct clinical and experimental characteristics in the patients younger than 60 years old with myelodysplastic syndromes.

Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia.

Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia.

Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma

Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer

P304

454-465

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28337274

http://www.w3.org/2001/XMLSchema#string

P921

cytotoxicity

P932

5340681

http://www.w3.org/2001/XMLSchema#string

Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes

about

P2860

P2860

Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P921

P932